Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > Valeant soon to become $1 like Concordia health
View:
Post by ahmi123 on May 24, 2017 3:20am

Valeant soon to become $1 like Concordia health

Quarter earnings had large tax benefits recovery due to losses. Many patents expiring 2017-2020 I can't believe how investors are still hoping where issues were very shocking, many litigations still open and more coming. Way too overvalued depending on issues
Comment by domcolumba on May 24, 2017 8:24am
Ahmi brilliant analysis of Valeant Pharmaceuticals. When you mentioned that number were you referring to your IQ or VRX shsre value. V affanculo idiota!
Comment by FerrariPalmbeac on May 24, 2017 8:48am
Deutsche Bank reiterated its $18usd price target on the drug stock -- territory not seen since late November -- saying it is "warming up" to the shares. Valeant Pharmaceuticals is now up 62% since its multi-year low of $8.31 from April 24, and VRX options traders have been buying to open calls over puts at a faster-than-usual clip. VRX stock has a 10-day call/put volume ratio of 3.30 at ...more  
Comment by Joe454 on May 24, 2017 9:00am
This post has been removed in accordance with Community Policy
VALEANT PHARMACEUTICALS INTL INC